Bruno Speder

Bruno Speder has extensive work experience in regulatory affairs and consultancy services. Bruno is currently serving as the VP of Regulatory Affairs at Poolbeg Pharma plc since July 2022. Prior to this, they held the position of VP of Regulatory Affairs & Consultancy Services at Open Orphan Plc starting from August 2020.

Before joining these companies, Bruno worked at SGS Life Science Services, S.A. where they served as the Head of Clinical Regulatory Affairs & Consultancy from January 2017 to August 2020. Bruno also worked at SGS Life Science Services from February 2014 to December 2016 as the Head of Clinical Regulatory Affairs, and from February 2012 to January 2014 as the Team Leader of Clinical Regulatory Affairs. Bruno started their career at SGS Life Science Services as a Regulatory Affairs Coordinator from September 2011 to February 2012 and as a Regulatory Affairs Associate from August 2008 to September 2011. In these roles, they were responsible for project management of clinical trial applications, advising client companies on regulatory strategies, and overseeing regulatory affairs for a wide range of therapeutic areas.

Bruno Speder pursued their tertiary education at Ghent University, where they obtained a degree in Bio-engineer in Cel- & Genetechnology from 2003 to 2007. Following this, they attended Ghent University once again in 2007 and 2008 to achieve a Master's degree in Business Economics, with a specialization in Economics. Continuing their educational journey, Bruno enrolled in the EHSAL Management School in 2009 and 2010 for a postgraduate program in Health Economics.